Advertisement

Patient Screening

  • Buechel Ronny
  • Gräni Christoph
  • Edwin Ho
  • Mizuki Miura
  • Alberto Pozzoli
  • Michael Gagesch
  • Gregor Freystätter
  • Heike A. Bischoff-Ferrari
  • Philipp Haager
  • Hans Rickli
  • Gudrun Feuchtner
  • Thomas Senoner
  • Michel Zuber
  • Francesco Maisano
  • Hatem Alkadhi
  • Philipp KaufmannEmail author
Chapter
  • 44 Downloads

Abstract

This second chapter is dedicated to the preoperative screening of patients, when the aortic disease has assumed a degree of severity that requires a thorough understanding in view of the treatment.

Which imaging tests are indicated for the diagnosis and quantification of the associated coronary artery disease, as well as mitral and tricuspidal valvulopathies will be discussed.

Cardiac tumours and incidental findings and the evaluation of the most relevant non-cardiac co-pathologies are discussed from the point of view of multimodal imaging techniques.

Particular attention will be given to the characterisation of the concept of “Frailty”, with state-of-the-art criteria of analysis provided to establish operability, assess the preoperative psychophysical and social conditions. This is to optimise treatment towards a true patient-tailored approach.

Finally, rare conditions associated with aortic disease, e.g. amyloidosis, and particular precautions in some settings (e.g. pregnant women, renal failure and the presence of cardiac pacemakers) will be illustrated.

Keywords

Frailty Aortic valve Aortic stenosis Aortic regurgitation Coronary angiography and functional assessment Echocardiography Cardiac computed tomography Cardiac magnetic resonance Angiography Positron emission tomography Assessment of concomitant cardiac pathologies Stress test Stress echocardiography 

References

  1. 1.
    Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.PubMedCrossRefGoogle Scholar
  2. 2.
    Lindsay AC, Sriharan M, Lazoura O, Sau A, Roughton M, Jabbour RJ, Di Mario C, Davies SW, Moat NE, Padley SP, Rubens MB, Nicol ED. Clinical and economic consequences of non-cardiac incidental findings detected on cardiovascular computed tomography performed prior to transcatheter aortic valve implantation (TAVI). Int J Cardiovasc Imaging. 2015;31(7):1435–46.PubMedCrossRefGoogle Scholar
  3. 3.
    van Kesteren F, Wiegerinck EMA, van Mourik MS, Vis MM, Koch KT, Piek JJ, Stoker J, Tijssen JG, Baan J Jr, Planken RN. Impact of potentially malignant incidental findings by computed tomographic angiography on long-term survival after transcatheter aortic valve implantation. Am J Cardiol. 2017;120(6):994–1001.PubMedCrossRefGoogle Scholar
  4. 4.
    Henn MC, Zajarias A, Lindman BR, Greenberg JW, Melby SJ, Quader N, Vatterott AM, Lawler C, Damiano MS, Novak E, Lasala JM, Moon MR, Lawton JS, Damiano RJ Jr, Maniar HS. Preoperative pulmonary function tests predict mortality after surgical or transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016;151(2):578–85, 586.e1-2.PubMedCrossRefGoogle Scholar
  5. 5.
    Afilalo J, Lauck S, Kim DH, Lefevre T, Piazza N, Lachapelle K, Martucci G, Lamy A, Labinaz M, Peterson MD, Arora RC, Noiseux N, Rassi A, Palacios IF, Genereux P, Lindman BR, Asgar AW, Kim CA, Trnkus A, Morais JA, Langlois Y, Rudski LG, Morin JF, Popma JJ, Webb JG, Perrault LP. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR Study. J Am Coll Cardiol. 2017;70(6):689–700.PubMedCrossRefGoogle Scholar
  6. 6.
    Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Paradis JM, Fried J, Nazif T, Kirtane A, Harjai K, Khalique O, Grubb K, George I, Hahn R, Williams M, Leon MB, Kodali S. Aortic stenosis and coronary artery disease: what do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms. Eur Heart J. 2014;35(31):2069–82.PubMedCrossRefGoogle Scholar
  8. 8.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159–95.PubMedCrossRefGoogle Scholar
  9. 9.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.PubMedCrossRefGoogle Scholar
  10. 10.
    Kotronias RA, Kwok CS, George S, Capodanno D, Ludman PF, Townend JN, Doshi SN, Khogali SS, Genereux P, Herrmann HC, Mamas MA, Bagur R. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6(6):e005960.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Huczek Z, Zbronski K, Grodecki K, Scislo P, Rymuza B, Kochman J, Dabrowski M, Witkowski A, Wojakowski W, Parma R, Ochala A, Grygier M, Olasinska-Wisniewska A, Araszkiewicz A, Jagielak D, Ciecwierz D, Puchta D, Paczwa K, Filipiak KJ, Wilimski R, Zembala M, Opolski G. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry. Catheter Cardiovasc Interv. 2018;91(1):115–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Sankaramangalam K, Banerjee K, Kandregula K, Mohananey D, Parashar A, Jones BM, Jobanputra Y, Mick S, Krishnaswamy A, Svensson LG, Kapadia SR. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis. J Am Heart Assoc. 2017;6(10):e006092.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Zivelonghi C, Pesarini G, Scarsini R, Lunardi M, Piccoli A, Ferrero V, Gottin L, Vassanelli C, Ribichini F. Coronary catheterization and percutaneous interventions after transcatheter aortic valve implantation. Am J Cardiol. 2017;120(4):625–31.PubMedCrossRefGoogle Scholar
  14. 14.
    Rossi A, De Cecco CN, Kennon SRO, Zou L, Meinel FG, Toscano W, Segreto S, Achenbach S, Hausleiter J, Schoepf UJ, Pugliese F. CT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2017;11(5):338–46.PubMedCrossRefGoogle Scholar
  15. 15.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.PubMedCrossRefGoogle Scholar
  16. 16.
    Cortes C, Amat-Santos IJ, Nombela-Franco L, Munoz-Garcia AJ, Gutierrez-Ibanes E, De La Torre Hernandez JM, Cordoba-Soriano JG, Jimenez-Quevedo P, Hernandez-Garcia JM, Gonzalez-Mansilla A, Ruano J, Jimenez-Mazuecos J, Castrodeza J, Tobar J, Islas F, Revilla A, Puri R, Puerto A, Gomez I, Rodes-Cabau J, San Roman JA. Mitral regurgitation after transcatheter aortic valve replacement: prognosis, imaging predictors, and potential management. JACC Cardiovasc Interv. 2016;9(15):1603–14.PubMedCrossRefGoogle Scholar
  17. 17.
    Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni F, Ruck A, Barbanti M, Toggweiler S, Thomas M, Khawaja MZ, Hutter A, Abramowitz Y, Siegel RJ, Cheng W, Webb J, Leon MB, Makkar RR. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;115(7):942–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Suh WM, Witzke CF, Palacios IF. Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76(4):616–20.PubMedCrossRefGoogle Scholar
  19. 19.
    Sorajja P, Booker JD, Rihal CS. Alcohol septal ablation after transaortic valve implantation: the dynamic nature of left outflow tract obstruction. Catheter Cardiovasc Interv. 2013;81(2):387–91.PubMedCrossRefGoogle Scholar
  20. 20.
    Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Douglas PS, Hoffmann U. Anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;373(1):91.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52(21):1724–32.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Nakazato R, Arsanjani R, Achenbach S, Gransar H, Cheng VY, Dunning A, Lin FY, Al-Mallah M, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Raff G, Shaw LJ, Villines T, Cury RC, Feuchtner G, Kim YJ, Leipsic J, Berman DS, Min JK. Age-related risk of major adverse cardiac event risk and coronary artery disease extent and severity by coronary CT angiography: results from 15 187 patients from the International Multisite CONFIRM Study. Eur Heart J Cardiovasc Imaging. 2014;15(5):586–94.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Leipsic J, Yang TH, Thompson A, Koo BK, Mancini GB, Taylor C, Budoff MJ, Park HB, Berman DS, Min JK. CT angiography (CTA) and diagnostic performance of noninvasive fractional flow reserve: results from the Determination of Fractional Flow Reserve by Anatomic CTA (DeFACTO) study. Am J Roentgenol. 2014;202(5):989–94.CrossRefGoogle Scholar
  25. 25.
    Hlatky MA, De Bruyne B, Pontone G, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Wilk A, Wang F, Rogers C, Douglas PS. Quality-of-life and economic outcomes of assessing fractional flow reserve with computed tomography angiography: PLATFORM. J Am Coll Cardiol. 2015;66(21):2315–23.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Thomsen C, Abdulla J. Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2016;17(2):120–9.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Ahmadi A, Leipsic J, Ovrehus KA, Gaur S, Bagiella E, Ko B, Dey D, LaRocca G, Jensen JM, Botker HE, Achenbach S, De Bruyne B, Norgaard BL, Narula J. Lesion-specific and vessel-related determinants of fractional flow reserve beyond coronary artery stenosis. JACC Cardiovasc Imaging. 2018;11(4):521–30.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Maurovich-Horvat P, Schlett CL, Alkadhi H, Nakano M, Otsuka F, Stolzmann P, Scheffel H, Ferencik M, Kriegel MF, Seifarth H, Virmani R, Hoffmann U. The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography. JACC Cardiovasc Imaging. 2012;5(12):1243–52.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Leber AW, Knez A, Becker A, Becker C, von Ziegler F, Nikolaou K, Rist C, Reiser M, White C, Steinbeck G, Boekstegers P. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol. 2004;43(7):1241–7.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, Dill KE, Jacobs JE, Maroules CD, Rubin GD, Rybicki FJ, Schoepf UJ, Shaw LJ, Stillman AE, White CS, Woodard PK, Leipsic JA. CAD-RADS (TM) Coronary Artery Disease—Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2016;10(4):269–81.PubMedCrossRefGoogle Scholar
  31. 31.
    Nakazato R, Otake H, Konishi A, Iwasaki M, Koo BK, Fukuya H, Shinke T, Hirata K, Leipsic J, Berman DS, Min JK. Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography. Eur Heart J Cardiovasc Imaging. 2015;16(4):373–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Eberhard M, Hinzpeter R, Polacin M, Morsbach F, Maisano F, Nietlispach F, Nguyen-Kim TDL, Tanner FC, Alkadhi H. Reproducibility of aortic valve calcification scoring with computed tomography–an interplatform analysis. J Cardiovasc Comput Tomogr. 2019;13(2):92–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Bettencourt N, Rocha J, Carvalho M, Leite D, Toschke AM, Melica B, Santos L, Rodrigues A, Goncalves M, Braga P, Teixeira M, Simoes L, Rajagopalan S, Gama V. Multislice computed tomography in the exclusion of coronary artery disease in patients with presurgical valve disease. Circ Cardiovasc Imaging. 2009;2(4):306–13.PubMedCrossRefGoogle Scholar
  34. 34.
    van den Boogert TPW, Vendrik J, Claessen B, Baan J, Beijk MA, Limpens J, Boekholdt SAM, Hoek R, Planken RN, Henriques JP. CTCA for detection of significant coronary artery disease in routine TAVI work-up: a systematic review and meta-analysis. Neth Heart J. 2018;26(12):591–9.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Singh G, Al’Aref SJ, Van Assen M, Kim TS, van Rosendael A, Kolli KK, Dwivedi A, Maliakal G, Pandey M, Wang J, Do V, Gummalla M, De Cecco CN, Min JK. Machine learning in cardiac CT: Basic concepts and contemporary data. J Cardiovasc Comput Tomogr. 2018;12(3):192–201.PubMedCrossRefGoogle Scholar
  36. 36.
    Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV, Anderson JL. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126(25):e354–471.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Mancini GB, Gosselin G, Chow B, Kostuk W, Stone J, Yvorchuk KJ, Abramson BL, Cartier R, Huckell V, Tardif JC, Connelly K, Ducas J, Farkouh ME, Gupta M, Juneau M, O’Neill B, Raggi P, Teo K, Verma S, Zimmermann R. Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease. Can J Cardiol. 2014;30(8):837–49.PubMedCrossRefGoogle Scholar
  38. 38.
    Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873–934.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, Edvardsen T, Garbi M, Ha JW, Kane GC, Kreeger J, Mertens L, Pibarot P, Picano E, Ryan T, Tsutsui JM, Varga A. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2016;17(11):1191–229.PubMedCrossRefGoogle Scholar
  40. 40.
    Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18(3):254–75.CrossRefGoogle Scholar
  41. 41.
    Pesarini G, Scarsini R, Zivelonghi C, Piccoli A, Gambaro A, Gottin L, Rossi A, Ferrero V, Vassanelli C, Ribichini F. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv. 2016;9(11):e004088.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–70.PubMedCrossRefGoogle Scholar
  43. 43.
    Norum IB, Ruddox V, Edvardsen T, Otterstad JE. Diagnostic accuracy of left ventricular longitudinal function by speckle tracking echocardiography to predict significant coronary artery stenosis. A systematic review. BMC Med Imaging. 2015;15:25.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Liou K, Negishi K, Ho S, Russell EA, Cranney G, Ooi SY. Detection of obstructive coronary artery disease using peak systolic global longitudinal strain derived by two-dimensional speckle-tracking: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2016;29(8):724–735.e4.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Caspar T, Samet H, Ohana M, Germain P, El Ghannudi S, Talha S, Morel O, Ohlmann P. Longitudinal 2D strain can help diagnose coronary artery disease in patients with suspected non-ST-elevation acute coronary syndrome but apparent normal global and segmental systolic function. Int J Cardiol. 2017;236:91–4.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Zuo HJ, Yang XT, Liu QG, Zhang Y, Zeng HS, Yan JT, Wang DW, Wang H. Global longitudinal strain at rest for detection of coronary artery disease in patients without diabetes mellitus. Curr Med Sci. 2018;38(3):413–21.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Alexandru Popescu B, Waggoner AD. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–60.PubMedCrossRefGoogle Scholar
  48. 48.
    Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation. 2007;115(11):1376–83.PubMedCrossRefGoogle Scholar
  49. 49.
    Dokainish H, Sengupta R, Pillai M, Bobek J, Lakkis N. Usefulness of new diastolic strain and strain rate indexes for the estimation of left ventricular filling pressure. Am J Cardiol. 2008;101(10):1504–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Singh A, Addetia K, Maffessanti F, Mor-Avi V, Lang RM. LA strain for categorization of LV diastolic dysfunction. JACC Cardiovasc Imaging. 2017;10(7):735–43.PubMedCrossRefGoogle Scholar
  51. 51.
    Porter TR, Mulvagh SL, Abdelmoneim SS, Becher H, Belcik JT, Bierig M, Choy J, Gaibazzi N, Gillam LD, Janardhanan R, Kutty S, Leong-Poi H, Lindner JR, Main ML, Mathias W Jr, Park MM, Senior R, Villanueva F. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018;31(3):241–74.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, Hayes SW, Cohen I, Germano G, Berman DS. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32(8):1012–24.PubMedCrossRefGoogle Scholar
  53. 53.
    Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11(2):171–85.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, Knuuti J, Maki M, Underwood RS, Min JK, Elmore K, Stuijfzand WJ, van Royen N, Tulevski II, Somsen AG, Huisman MC, van Lingen AA, Heymans MW, van de Ven PM, van Kuijk C, Lammertsma AA, van Rossum AC, Knaapen P. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol. 2017;2(10):1100–7.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Juarez-Orozco LE, Tio RA, Alexanderson E, Dweck M, Vliegenthart R, El Moumni M, Prakken N, Gonzalez-Godinez I, Slart R. Quantitative myocardial perfusion evaluation with positron emission tomography and the risk of cardiovascular events in patients with coronary artery disease: a systematic review of prognostic studies. Eur Heart J Cardiovasc Imaging. 2018;19(10):1179–87.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Unger P, Rosenhek R, Dedobbeleer C, Berrebi A, Lancellotti P. Management of multiple valve disease. Heart. 2011;97(4):272–7.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Unger P, Clavel MA, Lindman BR, Mathieu P, Pibarot P. Pathophysiology and management of multivalvular disease. Nat Rev Cardiol. 2016;13(7):429–40.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Vahanian A, Himbert D, Brochet E. Multiple valve disease—assessment, strategy and intervention. EuroIntervention. 2015;11(Suppl W):W14–6.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Grimaldi A, Vermi AC, Pappalardo F, Benussi S, Fumero A, Maisano F, Colombo A, La Canna G, Alfieri O. The pivotal role of echocardiography in the assessment of multivalvular heart disease. Minerva Cardioangiol. 2013;61(2):229–42.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, Horton K, Ogunyankin KO, Palma RA, Velazquez EJ. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64.PubMedCrossRefGoogle Scholar
  61. 61.
    Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71.PubMedCrossRefGoogle Scholar
  62. 62.
    Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611–44.PubMedCrossRefGoogle Scholar
  63. 63.
    Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg. 2014;118(1):21–68.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Flachskampf FA, Wouters PF, Edvardsen T, Evangelista A, Habib G, Hoffman P, Hoffmann R, Lancellotti P, Pepi M. Recommendations for transoesophageal echocardiography: EACVI update 2014. Eur Heart J Cardiovasc Imaging. 2014;15(4):353–65.PubMedCrossRefGoogle Scholar
  65. 65.
    Zamorano JL, Badano LP, Bruce C, Chan KL, Goncalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;32(17):2189–214.PubMedCrossRefGoogle Scholar
  66. 66.
    Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol. 2017;24(6):2043–63.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Tischler MD, Battle RW, Saha M, Niggel J, LeWinter MM. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J Am Coll Cardiol. 1995;25(1):128–33.PubMedCrossRefGoogle Scholar
  68. 68.
    Tunon J, Cordoba M, Rey M, Almeida P, Rabago R, Sanchez-Cascos A, Rabago P. Assessment of chronic tricuspid regurgitation by colour Doppler echocardiography: a comparison with angiography in the catheterization room. Eur Heart J. 1994;15(8):1074–84.PubMedCrossRefGoogle Scholar
  69. 69.
    Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M, Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–7.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Rodriguez-Manas L, Feart C, Mann G, Vina J, Chatterji S, Chodzko-Zajko W, Gonzalez-Colaco Harmand M, Bergman H, Carcaillon L, Nicholson C, Scuteri A, Sinclair A, Pelaez M, Van der Cammen T, Beland F, Bickenbach J, Delamarche P, Ferrucci L, Fried LP, Gutierrez-Robledo LM, Rockwood K, Rodriguez Artalejo F, Serviddio G, Vega E. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10.PubMedCrossRefGoogle Scholar
  72. 72.
    Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.PubMedCrossRefGoogle Scholar
  73. 73.
    Taramasso M, Pozzoli A, Buzzatti N, Alfieri O. Assessing operative risk and benefit in elderly patients with heart valve disease. Eur Heart J. 2013;34(36):2788–91.PubMedCrossRefGoogle Scholar
  74. 74.
    Rockwood K, Mogilner A, Mitnitski A. Changes with age in the distribution of a frailty index. Mech Ageing Dev. 2004;125(7):517–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue QL, Bandeen-Roche K, Varadhan R. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61.PubMedCrossRefGoogle Scholar
  76. 76.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014;6:192.PubMedPubMedCentralGoogle Scholar
  78. 78.
    Lin J, Lopez EF, Jin Y, Van Remmen H, Bauch T, Han HC, Lindsey ML. Age-related cardiac muscle sarcopenia: combining experimental and mathematical modeling to identify mechanisms. Exp Gerontol. 2008;43(4):296–306.PubMedCrossRefGoogle Scholar
  79. 79.
    Sayer AA. Sarcopenia. BMJ. 2010;341:c4097.PubMedCrossRefGoogle Scholar
  80. 80.
    Abellan van Kan G, Andre E, Bischoff Ferrari HA, Boirie Y, Onder G, Pahor M, Ritz P, Rolland Y, Sampaio C, Studenski S, Visser M, Vellas B. Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging. 2009;13(8):700–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Visser M. Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging. 2009;13(8):713–6.PubMedCrossRefGoogle Scholar
  83. 83.
    Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlogl M, Staehelin HB, Willett WC, Dawson-Hughes B. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26(12):2793–802.PubMedCrossRefGoogle Scholar
  84. 84.
    Dawson-Hughes B, Bischoff-Ferrari H. Considerations concerning the definition of sarcopenia: response to comments. Osteoporos Int. 2016;27(11):3147–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017;4(4):492–8.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Bekfani T, Pellicori P, Morris DA, Ebner N, Valentova M, Steinbeck L, Wachter R, Elsner S, Sliziuk V, Schefold JC, Sandek A, Doehner W, Cleland JG, Lainscak M, Anker SD, von Haehling S. Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. Int J Cardiol. 2016;222:41–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Saitoh M, Ebner N, von Haehling S, Anker SD, Springer J. Therapeutic considerations of sarcopenia in heart failure patients. Expert Rev Cardiovasc Ther. 2018;16(2):133–42.PubMedCrossRefGoogle Scholar
  88. 88.
    Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Kleczynski P, Tokarek T, Dziewierz A, Sorysz D, Bagienski M, Rzeszutko L, Dudek D. Usefulness of Psoas muscle area and volume and frailty scoring to predict outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2018;122(1):135–40.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Adams HS, Ashokkumar S, Newcomb A, MacIsaac AI, Whitbourn RJ, Palmer S. A contemporary review of severe aortic stenosis. Intern Med J. 2019;49(3):297–305.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Pulignano G, Gulizia MM, Baldasseroni S, Bedogni F, Cioffi G, Indolfi C, Romeo F, Murrone A, Musumeci F, Parolari A, Patane L, Pino PG, Mongiardo A, Spaccarotella C, Di Bartolomeo R, Musumeci G. ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement. Eur Heart J Suppl. 2017;19(Suppl D):D354–d369.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Sipers WM, Verdijk LB, Sipers SJ, Schols JM, van Loon LJ. The Martin Vigorimeter represents a reliable and more practical tool than the Jamar dynamometer to assess handgrip strength in the geriatric patient. J Am Med Dir Assoc. 2016;17(5):466.e1–7.CrossRefGoogle Scholar
  93. 93.
    Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55(4):M221–31.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Saum KU, Muller H, Stegmaier C, Hauer K, Raum E, Brenner H. Development and evaluation of a modification of the Fried frailty criteria using population-independent cutpoints. J Am Geriatr Soc. 2012;60(11):2110–5.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009;64(6):675–81.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Joseph SM, Manghelli JL, Vader JM, Keeney T, Novak EL, Felius J, Martinez SC, Nassif ME, Lima B, Silvestry SC, Rich MW. Prospective assessment of frailty using the fried criteria in patients undergoing left ventricular assist device therapy. Am J Cardiol. 2017;120(8):1349–54.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Ensrud KE, Blackwell TL, Redline S, Ancoli-Israel S, Paudel ML, Cawthon PM, Dam TT, Barrett-Connor E, Leung PC, Stone KL. Sleep disturbances and frailty status in older community-dwelling men. J Am Geriatr Soc. 2009;57(11):2085–93.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738–43.PubMedCrossRefGoogle Scholar
  99. 99.
    Cesari M, Marzetti E, Thiem U, Perez-Zepeda MU, Abellan Van Kan G, Landi F, Petrovic M, Cherubini A, Bernabei R. The geriatric management of frailty as paradigm of “The end of the disease era”. Eur J Intern Med. 2016;31:11–4.PubMedCrossRefGoogle Scholar
  100. 100.
    Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People, the Extended Group for E. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Chumlea WC, Cesari M, Evans WJ, Ferrucci L, Fielding RA, Pahor M, Studenski S, Vellas B, Members TTF. International working group on Sarcopenia. J Nutr Health Aging. 2011;15(6):450–5.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, Anker SD, Rutkove S, Vrijbloed JW, Isaac M, Rolland Y, M’Rini C, Aubertin-Leheudre M, Cedarbaum JM, Zamboni M, Sieber CC, Laurent D, Evans WJ, Roubenoff R, Morley JE, Vellas B. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle. 2012;3(3):181–90.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–63.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Chen WT, Chou KH, Liu LK, Lee PL, Lee WJ, Chen LK, Wang PN, Lin CP. Reduced cerebellar gray matter is a neural signature of physical frailty. Hum Brain Mapp. 2015;36(9):3666–76.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    McIsaac DI, Bryson GL, van Walraven C. Association of frailty and 1-year postoperative mortality following major elective noncardiac surgery: a population-based cohort study. JAMA Surg. 2016;151(6):538–45.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Mosquera C, Spaniolas K, Fitzgerald TL. Impact of frailty on surgical outcomes: the right patient for the right procedure. Surgery. 2016;160(2):272–80.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Dahya V, Xiao J, Prado CM, Burroughs P, McGee D, Silva AC, Hurt JE, Mohamed SG, Noel T, Batchelor W. Computed tomography-derived skeletal muscle index: a novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement. Am Heart J. 2016;182:21–7.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis. 2010;52(4):347–61.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006;166(17):1805–13.PubMedCrossRefGoogle Scholar
  111. 111.
    Sun JP, Stewart WJ, Yang XS, Donnell RO, Leon AR, Felner JM, Thomas JD, Merlino JD. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol. 2009;103(3):411–5.PubMedCrossRefGoogle Scholar
  112. 112.
    Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, Dierckx RA. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging. 2009;36(4):702–14.PubMedCrossRefGoogle Scholar
  113. 113.
    Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–12.PubMedCrossRefGoogle Scholar
  114. 114.
    American College of O, Gynecologists’ Committee on Obstetric P. Committee opinion no. 656: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2016;127(2):e75–80.CrossRefGoogle Scholar
  115. 115.
    Committee on Obstetric P. Committee opinion no. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130(4):e210–6.CrossRefGoogle Scholar
  116. 116.
    Leyendecker JR, Gorengaut V, Brown JJ. MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics. 2004;24(5):1301–16.PubMedCrossRefGoogle Scholar
  117. 117.
    Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112(2 Pt 1):333–40.PubMedCrossRefGoogle Scholar
  118. 118.
    Expert Panel on MRS, Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, Gimbel JR, Gosbee JW, Kuhni-Kaminski E, Larson PA, Lester JW Jr, Nyenhuis J, Schaefer DJ, Sebek EA, Weinreb J, Wilkoff BL, Woods TO, Lucey L, Hernandez D. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37(3):501–30.CrossRefGoogle Scholar
  119. 119.
    Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics. 2007;27(6):1705–22.PubMedCrossRefGoogle Scholar
  120. 120.
    Gjelsteen AC, Ching BH, Meyermann MW, Prager DA, Murphy TF, Berkey BD, Mitchell LA. CT, MRI, PET, PET/CT, and ultrasound in the evaluation of obstetric and gynecologic patients. Surg Clin North Am. 2008;88(2):361–90, vii.PubMedCrossRefGoogle Scholar
  121. 121.
    Webb JA, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital R. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15(6):1234–40.PubMedCrossRefGoogle Scholar
  122. 122.
    Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA, Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol. 2000;35(1):80–5.PubMedCrossRefGoogle Scholar
  123. 123.
    Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol. 2007;188(2):586–92.CrossRefGoogle Scholar
  124. 124.
    Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17(9):2359–62.PubMedCrossRefGoogle Scholar
  125. 125.
    Rahatli FK, Donmez FY, Kibaroglu S, Kesim C, Haberal KM, Turnaoglu H, Agildere AM. Does renal function affect gadolinium deposition in the brain? Eur J Radiol. 2018;104:33–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16(7):564–70.PubMedCrossRefGoogle Scholar
  127. 127.
    van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JAW, Thomsen HS. Post-contrast acute kidney injury—Part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2845–55.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JAW, Thomsen HS. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2856–69.PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42(12):1929–40.PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol. 2001;24(2):199–205.PubMedCrossRefGoogle Scholar
  131. 131.
    Nordbeck P, Weiss I, Ehses P, Ritter O, Warmuth M, Fidler F, Herold V, Jakob PM, Ladd ME, Quick HH, Bauer WR. Measuring RF-induced currents inside implants: impact of device configuration on MRI safety of cardiac pacemaker leads. Magn Reson Med. 2009;61(3):570–8.PubMedCrossRefGoogle Scholar
  132. 132.
    Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R, Boesiger P. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J. 2005;26(4):376–83; discussion 325–7.PubMedCrossRefGoogle Scholar
  133. 133.
    Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol. 2002;25(10):1419–23.PubMedCrossRefGoogle Scholar
  134. 134.
    Gimbel JR. Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a ‘modern’ pacemaker. Europace. 2009;11(9):1241–2.PubMedCrossRefGoogle Scholar
  135. 135.
    Ainslie M, Miller C, Brown B, Schmitt M. Cardiac MRI of patients with implanted electrical cardiac devices. Heart. 2014;100(5):363–9.PubMedCrossRefGoogle Scholar
  136. 136.
    Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, Dickfeld TL, Froelich JW, Grant J, Hayes DL, Heidbuchel H, Idriss SF, Kanal E, Lampert R, Machado CE, Mandrola JM, Nazarian S, Patton KK, Rozner MA, Russo RJ, Shen WK, Shinbane JS, Teo WS, Uribe W, Verma A, Wilkoff BL, Woodard PK. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14(7):e97–e153.PubMedCrossRefGoogle Scholar
  137. 137.
    Cao G, Chen W, Pan K, Sun H, Wang Z. Reduced artifacts and improved diagnostic value of 640-slice computed tomography in patients with cardiac pacemakers. J Int Med Res. 2019;47:1916–26.PubMedPubMedCentralCrossRefGoogle Scholar
  138. 138.
    Takayanagi T, Arai T, Amanuma M, Sano T, Ichiba M, Ishizaka K, Sekine T, Matsutani H, Morita H, Takase S. Pacemaker-induced metallic artifacts in coronary computed tomography angiography: clinical feasibility of single energy metal artifact reduction technique. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(6):460–6.PubMedCrossRefPubMedCentralGoogle Scholar
  139. 139.
    Marbach JR, Sontag MR, Van Dyk J, Wolbarst AB. Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group No. 34. American Association of Physicists in Medicine. Med Phys. 1994;21(1):85–90.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Buechel Ronny
    • 1
  • Gräni Christoph
    • 1
  • Edwin Ho
    • 2
  • Mizuki Miura
    • 2
  • Alberto Pozzoli
    • 2
  • Michael Gagesch
    • 3
    • 4
  • Gregor Freystätter
    • 3
    • 4
  • Heike A. Bischoff-Ferrari
    • 3
    • 4
  • Philipp Haager
    • 5
  • Hans Rickli
    • 5
  • Gudrun Feuchtner
    • 6
  • Thomas Senoner
    • 6
  • Michel Zuber
    • 7
  • Francesco Maisano
    • 2
  • Hatem Alkadhi
    • 8
  • Philipp Kaufmann
    • 1
    Email author
  1. 1.Department of Nuclear Medicine, Cardiac ImagingZurich University HospitalZurichSwitzerland
  2. 2.University Heart Center, Zurich University HospitalZurichSwitzerland
  3. 3.Department of GeriatricsZurich University HospitalZurichSwitzerland
  4. 4.Centre on Aging and Mobility, Zurich University Hospital, Waid City Hospital and University of ZurichZurichSwitzerland
  5. 5.Cardiology UnitKantonsspital St. GallenSt. GallenSwitzerland
  6. 6.Radiology UnitInnsbruck University HospitalInnsbruckAustria
  7. 7.Department of CardiologyZurich University HospitalZurichSwitzerland
  8. 8.Institute of Diagnostic and Interventional RadiologyZurich University HospitalZurichSwitzerland

Personalised recommendations